北海道大学大学院 薬学研究院 創薬科学研究教育センター 有機合成医薬学部門

研究業績

発表論文 2018年

  1. Improvement of SNAr Reaction Rate by an Electron-withdrawing Group in the Cross-linking of DNA Cytosine-5 Methyltransferase by a Covalent Oligodeoxyribonucleitode Inhibitor

    Yukiko Kasai; Kousuke Sato; Shohei Utsumi and Satoshi Ichikawa

    ChemBioChem, 2018, 19, 1866-1872.

    DOI: org/10.1002/cbic.201800244

     

    aa

  2. Insight into the recognition mechanism of DNA cytosine-5 methyltransferases (DNMTs) by incorporation of acyclic 5-fluorocytosine (FC) nucleosides into DNA

    Shohei Utsumi; Kousuke Sato; Satoshi Ichikawa

    Bioorg. Med. Chem. Lett. 2018, 28, 2189-2194.

    DOI: org/10.1016/j.bmcl.2018.05.008

     

    1-s2.0-S0960894X18303974-fx1

     

  3. Ribavirin-related compounds exert in vitro inhibitory effects toward rabies virus

    Anindita, Paulina D.; Sasaki, Michihito; Okada, Kazuma; Ito, Naoto; Sugiyama, Makoto; Saito-Tarashima, Noriko; Minakawa, Noriaki; Shuto, Satoshi; Otsuguro, Satoko; Ichikawa, Satoshi; Matsuda, Akira; Maenaka, Katsumi; Orba, Yasuko; Sawa, Hirofumi

    Antiviral Res. 2018, 154, 1-9.

    DOI: 10.1016/j.antiviral.2018.03.011

  4. Study of the structure-activity relationship of polymyxin analogues.

    Kinoshita, Yuhei; Yakushiji, Fumika; Matsui, Hidehito; Hanaki, Hideaki; and Ichikawa, Satoshi.*

    Bioorg. Med. Chem. Lett. 2018, 28, 2713-2716.

    DOI: 10.1016/j.bmcl.2018.03.028

     

    図1

  5. Total synthesis of plusbacin A3 and its dideoxy derivative using a solvent-dependent diastereodivergent Joullié–Ugi three-component reaction

    Akira Katsuyama, Fumika Yakushiji, and Satoshi Ichikawa

    J. Org. Chem. 2018, 83, 7085–7101.

    DOI: 10.1021/acs.joc.8b00038

     

    勝山さん_JOC  172 spine minimum. full size. Editor: Shawn/Katie JEM: Leslie RTP: Brian Deever/Theresa Massey

  6. GlcNAc-1-P-transferase–tunicamycin complex structure reveals basis for inhibition of N-glycosylation

    Jiho Yoo , Ellene H. Mashalidis , Alvin C. Y. Kuk , Kazuki Yamamoto, Benjamin Kaeser, Satoshi Ichikawa  and Seok-Yong Lee

    Nat. Struct. Mol. Biol. 2018, 25, 217-224.

    DOI: 10.1038/s41594-018-0031-y

     

    図4

  7. Mechanism-based Inhibitor of DNA Cytosine-5 Methyltransferase (DNMT) via a SNAr Reaction with an Oligodeoxyribonucleotide Containing 2-Amino-4-Halopyridine-C-Nucleoside (dXP)
    Kousuke Sato, Yuma Kunitomo, Yukiko Kasai, Shohei Utsumi, Isao Suetake, Shoji Tajima, Satoshi Ichikawa and Akira Matsuda.
    ChemBioChem, 2018, 19, 865-872. (as a very important paper)
    笠井さん、内海さん-Fp
  8. Solid-phase Modular Synthesis of Park Nucleotide and LipidⅠ and Lipid Ⅱ Analogues

    Akira Katsuyama, Kousuke Sato, Fumika Yakushiji, Takanori Matsumaru and Satoshi Ichikawa

    Chem. Pharm. Bull. 201866, 84-95. (Highlighted paper selected by Editor-in-Chief)

    DOI: 10.1248/cpb.c17-00828

     

    勝山さん neryl

  9. Potent anti-tumor activity of a syringolin analog in multiple myeloma: a dual inhibitor of proteasome activity targeting β2 and β5 subunits

    Takahashi Yoshida, Masaki Ri, Takashi Kanamori, Sho Aoki, Reham Ashour, Shiori Kinoshita, Tomoko Narita, Haruhito Totani, Ayako Masaki, Asahi Ito, Shigeru Kusumoto, Takashi Ishida, Hirokazu Komatsu, Shun Kitahata, Takuya Chiba, Satoshi Ichikawa and Shinsuke Iida

    Oncotarget20189, 9975-9991.

    DOI: 10.18632/oncotarget.24160

     

    syringolin

  10. Synthesis and Medicinal Chemistry of Muraymycins, Nucleoside Antibiotics

    Akira Katsuyama and Satoshi Ichikawa

    Chem. Pharm. Bull. (Review), 2018, 66, 123-131.

    DOI: 10.1248/cpb.c17-00684

     

    TOC

  11. Total Synthesis of Tunicamycin V

    Kazuki Yamamoto, Fumika Yakushiji, Takanori Matsumaru, and Satoshi Ichikawa

    Org. Lett. 201820, 256-259.

    DOI: 10.1021/acs.orglett.7b03623

     

    山本さん

Back